Revised SPC: Otezla (apremilast) Film-coated Tablets- all strengths

SPC has been updated with licence extension of treatment of adult patients with oral ulcers associated with Behçet's disease (BD) who are candidates for systemic therapy. Upper respiratory tract infection and headache have been added as common ADRs in BD.


electronic Medicines compendium